Intestinal transplantation: Evolution in immunosuppression protocols

Current Opinion in Organ Transplantation

Volumn 14, Issue 3, 2009, Pages 250-255

  Pirenne, Jacques ^a   Kawai, Masaru ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Immunomodulation; Immunosuppression; Intestinal transplantation; Short bowel syndrome; Total parenteral nutrition

Indexed keywords

ALEMTUZUMAB; AZATHIOPRINE; CYCLOSPORIN; CYCLOSPORIN A; GANCICLOVIR; IMMUNOGLOBULIN; INFLIXIMAB; INTERLEUKIN 2 RECEPTOR ANTIBODY; LYMPHOCYTE ANTIBODY; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; RAPAMYCIN; RITUXIMAB; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; ANTIVIRUS AGENT; IMMUNOSUPPRESSIVE AGENT;

ACUTE GRAFT REJECTION; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; CHRONIC GRAFT REJECTION; CLINICAL PROTOCOL; CROHN DISEASE; CYTOMEGALOVIRUS INFECTION; DIFFERENTIAL DIAGNOSIS; DRUG DOSE REDUCTION; DRUG MEGADOSE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GRAFT REJECTION; HERPES VIRUS INFECTION; HUMAN; IMMUNOGENICITY; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INTESTINE GRAFT REJECTION; INTESTINE ISCHEMIA; INTESTINE TRANSPLANTATION; LOW DRUG DOSE; LYMPHOPROLIFERATIVE DISEASE; NEOPLASM; PATIENT CARE; POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISEASE; PROTEINURIA; REVIEW; SHORT BOWEL SYNDROME; ADULT; CHILD; DRUG EFFECT; FEMALE; GRAFT SURVIVAL; HISTORY; IMMUNOLOGY; INTESTINE; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; PRESCHOOL CHILD; REGISTER; TRANSPLANTATION; TRANSPLANTATION TOLERANCE; TREATMENT OUTCOME;

ADULT; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INTESTINES; MALE; MIDDLE AGED; REGISTRIES; SHORT BOWEL SYNDROME; TRANSPLANTATION TOLERANCE; TREATMENT OUTCOME;

EID: 67651037576     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e32832b2eb7     Document Type: Review

References (29)

1. Li XC, Almawi W, Jevnikar A, et al. Allogeneic lymphocyte proliferation stimulated by small intestine-derived epithelial cells. Transplantation 1995; 60:82-89.
2. Kim IK, Bedi DS, Denecke C, et al. Impact of innate and adaptive immunity on rejection and tolerance. Transplantation 2008; 86:889-894.
3. Kawai M, Kitade H, Koshiba T, et al. Intestinal ischemia reperfusion injury and lipopolysaccharide transform a tolerogenic signal into a sensitizing signal and trigger rejection. Transplantation 2009 in press.
4. Chen L, Wang T, Zhou P, et al. TLR engagement prevents transplantation tolerance. Am J Transplant 2006; 6:2282-2291. (Pubitemid 44359413)
5. Zhang Z, Lazarovits A, Grant D, et al. CD45RB monoclonal antibody induces tolerance in the mouse kidney graft, but fails to prevent small bowel graft rejection. Transplant Proc 1996; 28:2514. (Pubitemid 26339369)
6. Matzinger P. The danger model: a renewed sense of self. Science 2002; 296:301-305. (Pubitemid 34303674)
7. Millar AJ, Gupte GL. Small bowel transplantation in children. Br J Hosp Med (Lond) 2007; 68:19-23. Another review of intestinal transplantation in children by the experienced team of Necker Hospital in Paris.
8. Vianna RM, Mangus RS, Tector AJ. Current status of small bowel and multivisceral transplantation. Adv Surg 2008; 42:129-150. This paper is an excellent review of intestinal transplantation by the team of Indianapolis.
9. Selvaggi G, Tzakis AG. Intestinal and multivisceral transplantation: future perspectives. Front Biosci 2007; 12:4742-4754. Future prospects of intestinal transplantation discussed by an ITx pioneer.
10. Sudan DL. Treatment of intestinal failure: intestinal transplantation. Nat Clin Pract Gastroenterol Hepatol 2007; 4:503-510. Another review by a renowned ITx expert from a pioneering center (Omaha).
11. Fryer JP. The current status of intestinal transplantation. Curr Opin Organ Transplant 2008; 13:266-272. Another review by a renowned ITx expert and researcher.
12. Pascher A, Klupp J, Langrehr JM, Neuhaus P. Anti-TNF-alpha therapy for acute rejection in intestinal transplantation. Transplant Proc 2005; 37:1635-1636. (Pubitemid 40712137)
13. Lauro A, Dazzi A, Ercolani G, et al. Rejection episodes and 3-year graft survival under sirolimus and tacrolimus treatment after adult intestinal transplantation. Transplant Proc 2007; 39:1629-1631. (Pubitemid 46907867)
14. Gillard P, Ling Z, Mathieu C, et al. Comparison of sirolimus alone with sirolimus plus tacrolimus in type 1 diabetic recipients of cultured islet cell grafts. Transplantation 2008; 85:256-263. (Pubitemid 351156856)
15. Pirenne J, Kawai M. Tolerogenic protocols for intestinal transplantation. Transpl Immunol 2004; 13:131-137.
16. Margreiter R. Development and importance of combined organ transplantation. Langenbecks Arch Chir Suppl Kongressbd 1992; 224-227.
17. Pirenne J, Kawai M. The protective effect of the liver: does it apply to the bowel too? Transplantation 2006; 81:978-979.
18. Abu-Elmagd K, Reyes J, Todo S, et al. Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg 1998; 186:512-525. (Pubitemid 28222074)
19. Pirenne J, Gruessner AC, Benedetti E, et al. Donor-specific unmodified bone marrow transfusion does not facilitate intestinal engraftment after bowel transplantation in a porcine model. Surgery 1997; 121:79-88. (Pubitemid 27043748)
20. Fudaba Y, Spitzer TR, Schaffer J, et al. Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses. Am J Transplant 2006; 6:2121-2133. (Pubitemid 44199546)
21. Donckier V, Troisi R, Le Moine A, et al. Early immunosuppression withdrawal after living donor liver transplantation and donor stem cell infusion. Liver Transpl 2006; 12:1523-1528. (Pubitemid 44594284)
22. Orloff SL, Yin Q, Corless CL, et al. Tolerance induced by bone marrow chimerism prevents transplant vascular necrosis in a rat model of small bowel transplant chronic rejection. Transplantation 2000; 69:1295-1303. (Pubitemid 30238714)
23. Bond GJ, Mazariegos GV, Sindhi R, et al. Evolutionary experience with immunosuppression in pediatric intestinal transplantation. J Pediatr Surg 2005; 40:274-279. (Pubitemid 40143571)
24. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003; 3:199-210.
25. Pirenne J, Kawai M. Tolerogenic protocol for intestinal transplantation. Transplant Proc 2006; 38:1664-1667.
26. Pirenne J, Koshiba T, Geboes K, et al. Complete freedom from rejection after intestinal transplantation using a new tolerogenic protocol combined with low immunosuppression. Transplantation 2002; 73:966-968. (Pubitemid 34252364)
27. Kitade H, Kawai M, Rutgeerts O, et al. Early presence of regulatory cells in transplanted rats rendered tolerant by donor-specific blood transfusion. J Immunol 2005; 175:4963-4970. (Pubitemid 41456378)
28. Koshiba T, Van Damme B, Ji P, et al. Addition of steroids blocks the tolerogenic potential of donor-specific blood transfusion. Transplant Proc 2001; 33:375-376. (Pubitemid 32237424)
29. Kawai M, Kitade H, Mathieu C, et al. Inhibitory and stimulatory effects of cyclosporine A on the development of regulatory T cells in vivo. Transplantation 2005; 79:1073-1077. (Pubitemid 40664000)